[HTML][HTML] Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries

T Zhao, W Wu, L Sui, Q Huang, Y Nan, J Liu, K Ai - Bioactive Materials, 2022 - Elsevier
Interventional coronary reperfusion strategies are widely adopted to treat acute myocardial
infarction, but morbidity and mortality of acute myocardial infarction are still high …

[HTML][HTML] Reactive-oxygen-species-scavenging nanomaterials for resolving inflammation

X Huang, D He, Z Pan, G Luo, J Deng - Materials Today Bio, 2021 - Elsevier
Reactive oxygen species (ROS) mediate multiple physiological functions; however, the over-
accumulation of ROS causes premature aging and/or death and is associated with various …

Dual‐stage‐light‐guided tumor inhibition by mitochondria‐targeted photodynamic therapy

K Han, Q Lei, SB Wang, JJ Hu, WX Qiu… - Advanced Functional …, 2015 - Wiley Online Library
In this paper, a self‐delivery system PpIX‐PEG‐(KLAKLAK) 2 (designated as PPK) is
fabricated to realize mitochondria‐targeted photodynamic tumor therapy. It is found that the …

[HTML][HTML] Reactive oxygen species (ROS)-responsive nanomedicine for solving ischemia-reperfusion injury

W Chen, D Li - Frontiers in Chemistry, 2020 - frontiersin.org
Ischemia-reperfusion injury (IRI) is a severe condition for most organs, which could occur in
various tissues including brain, heart, liver, and kidney, etc. As one of the major hazards …

Recent advances in nanomedicines for imaging and therapy of myocardial ischemia-reperfusion injury

J Wang, Y Liu, Y Liu, H Huang, S Roy, Z Song… - Journal of Controlled …, 2023 - Elsevier
Myocardial ischemia-reperfusion injury (IRI) is becoming a typical cardiovascular disease
with increasing worldwide incidence. It is usually induced by the restoration of normal blood …

Multiscale technologies for treatment of ischemic cardiomyopathy

M Mahmoudi, M Yu, V Serpooshan, JC Wu… - Nature …, 2017 - nature.com
The adult mammalian heart possesses only limited capacity for innate regeneration and the
response to severe injury is dominated by the formation of scar tissue. Current therapy to …

Current advances in the use of nanophytomedicine therapies for human cardiovascular diseases

M Hesari, P Mohammadi, F Khademi… - International journal …, 2021 - Taylor & Francis
Considering the high prevalence of cardiovascular diseases (CVDs), the primary cause of
death during the last several decades, it is necessary to develop proper strategies for the …

An overview of nanotoxicity and nanomedicine research: principles, progress and implications for cancer therapy

Y Wang, A Santos, A Evdokiou, D Losic - Journal of Materials …, 2015 - pubs.rsc.org
The toxic paradigms of chemotherapeutic drugs and nanoparticles are tightly linked.
Whereas uncontrolled exposure of living systems to therapeutics/nanomaterials leads to …

[HTML][HTML] Therapeutic applications of curcumin nanomedicine formulations in cardiovascular diseases

B Salehi, ML Del Prado-Audelo, H Cortés… - Journal of clinical …, 2020 - mdpi.com
Cardiovascular diseases (CVD) compromises a group of heart and blood vessels disorders
with high impact on human health and wellbeing. Curcumin (CUR) have demonstrated …

Protective effects of curcumin on ischemia/reperfusion injury

M Mohamadian, N Parsamanesh, H Chiti… - Phytotherapy …, 2022 - Wiley Online Library
Abstract Ischemia/reperfusion (I/R) injury is a term used to describe phenomena connected
to the dysfunction of various tissue damage due to reperfusion after ischemic injury. While …